/channels/news_feeds/all/term/Christel%20Renoux/rss en /channels/channels/news/findings-suggest-certain-medications-type-2-diabetes-reduce-risk-dementia-370312 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p>A large 91ºÚÁÏÍø study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.</p> <p>Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.</p> <p><a href="https://link.springer.com/article/10.1007/s40264-025-01623-9">The study</a> examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.</p></div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/glp-1.jpg?itok=uFwMIAZ-" width="160" height="107" alt="" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">15 </span><span class="month">January </span><span class="year">2026</span></div></div></div></div></div> Thu, 15 Jan 2026 14:02:20 +0000 webfull 214818 at /channels